CClinicalTrials.gg
RecruitingNCT06436508Updated May 31, 2024

The Investigation of the Impact of Early Mobilization on the Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.

An interventional study of Early mobilization protocol and Standard care in Early Ambulation, Standard of Care and Subarachnoid Hemorrhage, Aneurysmal, sponsored by University of Pecs. Recruiting at 3 sites in Hungary. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-05-31.

Sponsored by University of Pecs · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jun 2023, registered Feb 2024).
  • Started Jun 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The goal of the randomized clinical trial is to examine the effect of early mobilization on primary and secondary outcomes in patients with subarachnoid hemorrhage caused by aneurysm rupture.

Researchers will compare early mobiliziation vs. standrad bed rest care.

02

Conditions studied

  • Early Ambulation
  • Standard of Care
  • Subarachnoid Hemorrhage, Aneurysmal

Keywords

  • subarachnoid hemorrhage
  • early mobilization
03

In context

Subarachnoid Hemorrhage

509 studies on the registry are indexed under Subarachnoid Hemorrhage; 124 are open to participants now.

This study's planned enrollment of 50 is close to the median of 52 across 263 interventional studies indexed under Subarachnoid Hemorrhage.

Browse Subarachnoid Hemorrhage studies →

Lead sponsor

University of Pecs is the lead sponsor of 100 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age >18 ys
  • Premorbid modified Rankin Scale score of 0-2
  • WFNS I-IV at enrollment
  • Aneurysm occlusion has occurred through open or endovascular means
  • Minimum 24 hours elapsed after aneurysm occlusion
  • The patient has not received thrombolytic therapy
  • Vital parameters are appropriate (mean arterial pressure [MAP] >80 or >110 mm Hg)
  • Signed patient information and consent form
  • Enrollment occurs within 72 hours following ictus

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Traumatic subarachnoid hemorrhage
  • Incapacitated or limited capacity for action before ictus
  • Confirmed pregnancy
  • Aneurysm multiplicity (unless all aneurysms are treated)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Early mobilization

    This group is mobilized in the intensive care unit by the institutional physiotherapist with the assistance of specialized personnel. Mobilization is carried out according to the Early Mobilization Protocol (EMP) Early mobilization protocol: * Step 1 - Day 1: Bed rest, elevation of the head end to 30° * Step 2 - Day 2: Bed rest, elevation of the head end to 60° * Step 3 - Day 3: Bed rest, elevation of the head end to 80° * Step 4 - Day 4: Sitting on the edge of the bed * Step 5 - Day 5: Sitting in a chair, standing up * Step 6 - Day 6: Walking with or without assistance * Step 7 - Day 7: Walking with or without assistance from today

    Behavioral: Early mobilization protocol

  • Active comparator
    Standard bed rest

    No early mobilization

    Behavioral: Standard care

Interventions

  • BehavioralEarly mobilization protocol

    * Step 1 - Day 1: Bed rest, elevation of the head end to 30° * Step 2 - Day 2: Bed rest, elevation of the head end to 60° * Step 3 - Day 3: Bed rest, elevation of the head end to 80° * Step 4 - Day 4: Sitting on the edge of the bed * Step 5 - Day 5: Sitting in a chair, standing up * Step 6 - Day 6: Walking with or without assistance * Step 7 - Day 7: Walking with or without assistance from today

  • BehavioralStandard care

    During standard care, early mobilization does not take place in the intensive care unit; the patient receives only standard supportive care in bed rest.

06

What researchers measure

Primary outcomes

  1. Disability in early mobilization group (EM) vs. standard care group (SC) - modified Rankin score

    Outcome assessments will include: Modified Rankin Scale Disability is assessed by the modified Rankin Scale, dichotomized at a score of 0 to 3 versus 4 to 6 (6=death).Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day; 3 months

  2. Disability in early mobilization group (EM) vs. standard care group (SC) - Extended Glasgow Outcome Scale

    Extended Glasgow Outcome Scale Description of the neurological outcome by using extended Glasgow Outcome Score 1. Death 2. Vegetative sate 3. Lower severe disability 4. Upper severe disability 5. Lower moderate disability 6. Upper moderate disability 7. Lower good recovery 8. Upper good recovery Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day; 3 months

Secondary outcomes

  1. Onset of delayed cerebral ischemia (DCI)

    Occurence of DCI after aneurysmal subarachnoid hemorrhage

    Time frame: 3-21 days

  2. Onset of severity of macrovascular vasospasm

    based on cerebral vasospasm grade Grade 0 All intracranial vessels show a physiological shape Grade 1 Vasospasm affects the A2, A1, and M2 segments Grade 2 Vasospasm expands to the M1 and terminal segment of the internal carotid artery Grade 3 Severe reduction in the intradural internal carotid artery with filiform A1 and M1 segments, which sometimes appears like a ghost (ghost sign)

    Time frame: Up to 14 days

  3. Stay in the Intensive Care Unit (ICU)

    Length of stay in the Intensive Care Unit (ICU)

    Time frame: Up to 28 days

  4. Type of post-hospital discharge placement

    home discharge, rehabilitation, chronic care, etc.

    Time frame: Up to 30 days

  5. Readmission to the ICU

    repeated ICU treatment following ward discharge

    Time frame: Up to 30 days

  6. Occurrence of infection and its time in the intensive care unit

    infection and its time in the intensive care unit

    Time frame: Up to 30 days

  7. Barthel score

    For assessing activities of daily living in patients with aneurysmal subarachnoid hemorrhage; ordinal scale rates bowel function, bladder function, grooming, toilet use, feeding independence, transfer independence, mobility, dressing ability, stair use, and bathing ability to tabulate a composite score ranging from 0 to 100. Score of 100 represents totally independent. Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day; 3 months

  8. Functional Independence Measure (FIM) scale

    The FIM's assessment of degree of disability depends on the patient's score in 18 categories, focusing on motor and cognitive function. Each category or item is rated on a 7-point scale (1 = \<25% independence; total assistance required, 7 = 100% independence) Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day

  9. Montreal Cognitive Assessment (MoCA)

    MoCA scores range between 0 and 30. The MoCA is used for assessment for detecting cognitive impairment. A score of 26 or over is considered to be normal. Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day; 3 months

  10. Hospital Anxiety and Depression Scale (HADS)

    Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. Items are rated on a 4-point severity scale. The HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Scores of greater than or equal to 11 on either scale indicate a definitive case. Assessment is performed by a blinded investigator of the local study center by personal visit.

    Time frame: 14 day; 3 months

07

Study locations

3 of 3 sites recruiting
  • University of Pecs
    Pécs, Baranya 7624, Hungary
    • Peter Csecsei, MD. PhD · Contact
    Recruiting
  • Central Hospital of B.A.Z. County
    Miskolc, BAZ 3526, Hungary
    • Csaba Olah, MD. PhD · Contact
    Recruiting
  • National Institute of Mental Health, Neurology, and Neurosurgery
    Budapest, 1145, Hungary
    • Sandor Nardai, MD. PhD · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Investigators will use external resources for an appropriate repository for their data

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06436508
Lead sponsor
University of Pecs
Collaborators
National Institute of Mental, Neurological and Neurosurgery, Borsod-Abaúj-Zemplén County Central Hospital and University Teaching Hospital
Responsible party
Péter Csécsei (Assistant Professor, University of Pecs) — Principal investigator
First posted
May 31, 2024
Start date
Jun 14, 2023
Primary completion
Jan 31, 2025 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
May 31, 2024

Study contacts

Peter Csecsei, MD. PhD
Contact
csecsei.peter@pte.hu
+0672535900
Peter Csecsei, MD. PhD
principal investigator · University of Pecs

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion